Niels Wolfhagen , Quirine J.J. Boldingh , Wouter J. Bom , Linda M. Posthuma , Jochem C.G. Scheijmans , Bart M.F. van der Leeuw , Joost A.B. van der Hoeven , Jens-Peter Hering , Dirk J.A. Sonneveld , Otto E. van Geffen , Eduard R. Hendriks , Ewoud B. Kluyver , Ahmet Demirkiran , Luc R.C.W. van Lonkhuijzen , Marcel G.W. Dijkgraaf , Markus W. Hollmann , Marja A. Boermeester , Stijn W. de Jonge
{"title":"为预防腹部手术后手术部位感染,标准护理与标准护理相结合的护理包(EPO2CH试验):一项随机、开放标签、实用、优势的多中心试验","authors":"Niels Wolfhagen , Quirine J.J. Boldingh , Wouter J. Bom , Linda M. Posthuma , Jochem C.G. Scheijmans , Bart M.F. van der Leeuw , Joost A.B. van der Hoeven , Jens-Peter Hering , Dirk J.A. Sonneveld , Otto E. van Geffen , Eduard R. Hendriks , Ewoud B. Kluyver , Ahmet Demirkiran , Luc R.C.W. van Lonkhuijzen , Marcel G.W. Dijkgraaf , Markus W. Hollmann , Marja A. Boermeester , Stijn W. de Jonge","doi":"10.1016/j.lanepe.2025.101448","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Surgical site infections (SSI) are common. We selected five interventions from recent SSI prevention guidelines, to form the Enhanced PeriOperative Care and Health program (EPO<sub>2</sub>CH), a perioperative care bundle. We aimed to investigate the effect of the EPO<sub>2</sub>CH bundle on the incidence of SSI.</div></div><div><h3>Methods</h3><div>The EPO<sub>2</sub>CH trial concerns an open label, pragmatic, randomised controlled parallel-group multicentre trial, in which we assigned patients, scheduled for elective abdominal surgery with incisions larger than five centimetres, to either standard care or standard care plus the EPO<sub>2</sub>CH bundle consisting of intraoperative high fraction of inspired oxygen; Goal-Directed Fluid Therapy; normothermia; perioperative glucose control; and incisional wound irrigation. The study was conducted in seven hospitals in the Netherlands. Patients were randomised per hospital per day in a 1:1 ratio with variable block sizes using an internet-based automated assignment system. The primary outcome was the incidence of SSI within 30 days in the intention-to-treat population. This study is registered at CCMO register (NL-OMON50566).</div></div><div><h3>Findings</h3><div>Between March 1st, 2016, and March 26th, 2020, 1777 patients were included. The intervention group included 869 patients (mean age 63.1, 467 female and 402 male) versus 908 in the control group (mean age 64.0, 530 female and 378 male). The incidence of SSI was 18.4% (160/869) in the intervention and 18.9% (172/908) in the control group; relative risk 0.98 (95% CI: 0.81–1.18) in the intention-to-treat analysis and 0.91 (95% CI: 0.60–1.37) in the per-protocol analysis. The percentage of patients with a serious adverse event was 33.3% (289/869) versus 33.5% (304/908), RR 0.99, 95% CI 0.87–1.23.</div></div><div><h3>Interpretation</h3><div>In a high-income health care setting, a care bundle did not lead to a lower incidence of surgical site infections when added to standard care including preoperative systemic antibiotic prophylaxis and alcohol-based surgical skin preparation. Considering the persistent high risk of SSI, research into interventions that may help to reduce this risk remains urgently needed.</div></div><div><h3>Funding</h3><div>The <span>Netherlands Organisation for Health Research and Development</span> (ZonMW), and co-financed by <span>Innovatiefonds Zorgverzekeraars</span>, and <span>Ethicon</span>.</div></div>","PeriodicalId":53223,"journal":{"name":"Lancet Regional Health-Europe","volume":"58 ","pages":"Article 101448"},"PeriodicalIF":13.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A care bundle added to standard care versus standard care for the prevention of surgical site infections after abdominal surgery (EPO2CH trial): a randomised, open label, pragmatic, superiority multicentre trial\",\"authors\":\"Niels Wolfhagen , Quirine J.J. Boldingh , Wouter J. Bom , Linda M. Posthuma , Jochem C.G. Scheijmans , Bart M.F. van der Leeuw , Joost A.B. van der Hoeven , Jens-Peter Hering , Dirk J.A. Sonneveld , Otto E. van Geffen , Eduard R. Hendriks , Ewoud B. Kluyver , Ahmet Demirkiran , Luc R.C.W. van Lonkhuijzen , Marcel G.W. Dijkgraaf , Markus W. Hollmann , Marja A. Boermeester , Stijn W. de Jonge\",\"doi\":\"10.1016/j.lanepe.2025.101448\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Surgical site infections (SSI) are common. We selected five interventions from recent SSI prevention guidelines, to form the Enhanced PeriOperative Care and Health program (EPO<sub>2</sub>CH), a perioperative care bundle. We aimed to investigate the effect of the EPO<sub>2</sub>CH bundle on the incidence of SSI.</div></div><div><h3>Methods</h3><div>The EPO<sub>2</sub>CH trial concerns an open label, pragmatic, randomised controlled parallel-group multicentre trial, in which we assigned patients, scheduled for elective abdominal surgery with incisions larger than five centimetres, to either standard care or standard care plus the EPO<sub>2</sub>CH bundle consisting of intraoperative high fraction of inspired oxygen; Goal-Directed Fluid Therapy; normothermia; perioperative glucose control; and incisional wound irrigation. The study was conducted in seven hospitals in the Netherlands. Patients were randomised per hospital per day in a 1:1 ratio with variable block sizes using an internet-based automated assignment system. The primary outcome was the incidence of SSI within 30 days in the intention-to-treat population. This study is registered at CCMO register (NL-OMON50566).</div></div><div><h3>Findings</h3><div>Between March 1st, 2016, and March 26th, 2020, 1777 patients were included. The intervention group included 869 patients (mean age 63.1, 467 female and 402 male) versus 908 in the control group (mean age 64.0, 530 female and 378 male). The incidence of SSI was 18.4% (160/869) in the intervention and 18.9% (172/908) in the control group; relative risk 0.98 (95% CI: 0.81–1.18) in the intention-to-treat analysis and 0.91 (95% CI: 0.60–1.37) in the per-protocol analysis. The percentage of patients with a serious adverse event was 33.3% (289/869) versus 33.5% (304/908), RR 0.99, 95% CI 0.87–1.23.</div></div><div><h3>Interpretation</h3><div>In a high-income health care setting, a care bundle did not lead to a lower incidence of surgical site infections when added to standard care including preoperative systemic antibiotic prophylaxis and alcohol-based surgical skin preparation. Considering the persistent high risk of SSI, research into interventions that may help to reduce this risk remains urgently needed.</div></div><div><h3>Funding</h3><div>The <span>Netherlands Organisation for Health Research and Development</span> (ZonMW), and co-financed by <span>Innovatiefonds Zorgverzekeraars</span>, and <span>Ethicon</span>.</div></div>\",\"PeriodicalId\":53223,\"journal\":{\"name\":\"Lancet Regional Health-Europe\",\"volume\":\"58 \",\"pages\":\"Article 101448\"},\"PeriodicalIF\":13.0000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Regional Health-Europe\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666776225002406\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Europe","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666776225002406","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
A care bundle added to standard care versus standard care for the prevention of surgical site infections after abdominal surgery (EPO2CH trial): a randomised, open label, pragmatic, superiority multicentre trial
Background
Surgical site infections (SSI) are common. We selected five interventions from recent SSI prevention guidelines, to form the Enhanced PeriOperative Care and Health program (EPO2CH), a perioperative care bundle. We aimed to investigate the effect of the EPO2CH bundle on the incidence of SSI.
Methods
The EPO2CH trial concerns an open label, pragmatic, randomised controlled parallel-group multicentre trial, in which we assigned patients, scheduled for elective abdominal surgery with incisions larger than five centimetres, to either standard care or standard care plus the EPO2CH bundle consisting of intraoperative high fraction of inspired oxygen; Goal-Directed Fluid Therapy; normothermia; perioperative glucose control; and incisional wound irrigation. The study was conducted in seven hospitals in the Netherlands. Patients were randomised per hospital per day in a 1:1 ratio with variable block sizes using an internet-based automated assignment system. The primary outcome was the incidence of SSI within 30 days in the intention-to-treat population. This study is registered at CCMO register (NL-OMON50566).
Findings
Between March 1st, 2016, and March 26th, 2020, 1777 patients were included. The intervention group included 869 patients (mean age 63.1, 467 female and 402 male) versus 908 in the control group (mean age 64.0, 530 female and 378 male). The incidence of SSI was 18.4% (160/869) in the intervention and 18.9% (172/908) in the control group; relative risk 0.98 (95% CI: 0.81–1.18) in the intention-to-treat analysis and 0.91 (95% CI: 0.60–1.37) in the per-protocol analysis. The percentage of patients with a serious adverse event was 33.3% (289/869) versus 33.5% (304/908), RR 0.99, 95% CI 0.87–1.23.
Interpretation
In a high-income health care setting, a care bundle did not lead to a lower incidence of surgical site infections when added to standard care including preoperative systemic antibiotic prophylaxis and alcohol-based surgical skin preparation. Considering the persistent high risk of SSI, research into interventions that may help to reduce this risk remains urgently needed.
Funding
The Netherlands Organisation for Health Research and Development (ZonMW), and co-financed by Innovatiefonds Zorgverzekeraars, and Ethicon.
期刊介绍:
The Lancet Regional Health – Europe, a gold open access journal, is part of The Lancet's global effort to promote healthcare quality and accessibility worldwide. It focuses on advancing clinical practice and health policy in the European region to enhance health outcomes. The journal publishes high-quality original research advocating changes in clinical practice and health policy. It also includes reviews, commentaries, and opinion pieces on regional health topics, such as infection and disease prevention, healthy aging, and reducing health disparities.